Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study

Annals of Hepatology

Volumn 12, Issue 1, 2013, Pages 70-77

  Grattagliano, Ignazio ^a   Ubaldi, Enzo ^a   Napoli, Luigi ^a   Marulli, Carlo Fedele ^a   Nebiacolombo, Cristina ^a   Cottone, Carmelo ^a   Portincasa, Piero ^b  

^a Italian College of General Practitioners   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Fatty liver; Fibromax; General practice; Liver fibrosis; Primary care

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; TRIACYLGLYCEROL; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALGORITHM; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FATTY LIVER INDEX; FEMALE; GENERAL PRACTICE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRANSAMINASEMIA; ITALY; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; OBESITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; WAIST CIRCUMFERENCE; AGE; BLOOD; COMORBIDITY; FATTY LIVER; INSULIN RESISTANCE; LIVER; LIVER CIRRHOSIS; METABOLIC SYNDROME X; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; AGE FACTORS; ALANINE TRANSAMINASE; ALGORITHMS; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FAMILY PRACTICE; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; ITALY; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

MLCS; MLOWN;

EID: 84878765204     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31387-0     Document Type: Article

References (30)

1. Baumeister SE, Volzke H, Marschall P, John U, Schmidt CO, Flessa S, Alte D. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 2008; 134: 85-94.
2. Anstee QM, McPherson S, Day CP. How big a problem is non-alcoholic fatty liver disease? BMJ 2011; 343: d3897.
3. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. Clin Biochem 2005; 38: 203-17.
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50.
5. Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, Becker U, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53: 750-5.
6. Cortez-Pinto H, Baptista A, Camilo ME, de Moura MC. Nonalcoholic steatohepatitis-a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients. Dig Dis Sci 2003; 48: 1909-13.
7. Spycher C, Zimmermann A, Reichen J. The diagnostic value of liver biopsy. BMC Gastroenterol 2001; 1: 12.
8. Grattagliano I, Portincasa P, Palasciano G. Liver disease: Early signs you may be missing. J Fam Pract 2009; 58: 514-21.
9. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
10. Castera L, Vergniol J, Foucher J, Le BB, Chanteloup E, Haaser M, Darriet M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
11. Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician 2007; 53: 857-63.
12. Grattagliano I, D'Ambrosio G, Palmieri VO, Moschetta A, Palasciano G, Portincasa P. Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis 2008; 17: 389-94.
13. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007; 30: 2119-21.
14. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588-94.
15. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
16. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
17. Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, et al. Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 2001; 35: 568-74.
18. Loguercio C, De Simone T, D'Auria MV, de Sio I, Federico A, Tuccillo C, Abbatecola AM, et al. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig Liver Dis 2004; 36: 398-405.
19. Stroffolini T, Sagnelli E, Mele A, Craxi A, Almasio P. The aetiology of chronic hepatitis in Italy: results from a multicentre national study. Dig Liver Dis 2004; 36: 829-33.
20. Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis. Med Clin North Am 1996; 80: 1147-66.
21. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris HT, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990; 85: 1349-55.
22. Loguercio C, Tiso A, Cotticelli G, Del Vecchio Blanco C, Arpino G, Laringe M, Napoli L, et al. Management of chronic liver disease by general practitioners in Southern Italy: Unmet educational needs. Dig Liver Dis 2011; 43: 736-41.
23. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4: 10.
24. Grattagliano I, Caraceni P, Calamita G, Ferri D, Gargano I, Palasciano G, Portincasa P. Severe liver steatosis correlates with nitrosative and oxidative stress in rats. Eur J Clin Invest 2008; 38: 523-30.
25. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-92.
26. Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, et al. Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol 2004; 41: 751-7.
27. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006; 111: 135-43.
28. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
29. Loria P, Lonardo A, Lombardini S, Carulli L, Verrone A, Ganazzi D, Rudilosso A, et al. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors. J Gastroenterol Hepatol 2005; 20: 1176-84.
30. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997; 26: 809-18.